Introducing a new business model for CMOs implementing serialization

This FREE webinar was recorded on:
09:00 AM - 10:00 AM EST

To view this webinar, please fill out the form to register and become a Pharmaceuticals & Biotechnology member.
Or, if you're already a Pharmaceuticals & Biotechnology member, sign in below to view.

By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product and you agree to our User Agreement, Privacy Policy, and Cookie Policy.

Important Note: Please scroll to the bottom of the page for the form to immediately access the webinar

This webinar hosted by industry experts, Bob Celeste, former Director at GS1 Healthcare US and Torben Vogt,Global PharmaDirector at Videojet Technologies examines the options that CMOs and pharma SMEs have when implementing serialization, and the challenges involved in these processes.

Benefits of attending this webinar: 

  1. Be one of the first to hear about an innovative new business model proposal for CMOs to help reduce costs and complexity from serialization implementation.
  2. Get helpful/practical tips on overcoming the main challenges of implementation. 
  3. Hear answers from highly experienced speakers who can discuss approaches and offer ideas for handling Track & Trace compliance transition. 

Challenges this webinar addresses:

  1. Finding cost effective solutions that reduce the complexity from implementation of serialization.
  2. Getting the code format right - one of the critical parts of the project
  3. Choosing the right printing technology for your business - pros and cos and tools to help you select

Pharma & biotech professionals who should view this webinar: 

Project/Planning Managers, Engineering Managers, Production Managers, Quality Managers, Line Managers, Site Managers, CEO, Operations Managers. 

Access the webinar on demand today

Have Your Say
Rate this feature and give us your feedback in the comments section below


Bob Celeste Founder Center for Supply Chain Studies
Torben Vogt Global Pharma Director Videojet Technologies Ltd